- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 25.37M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $59.1M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $59.07M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $200M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $238.96M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $82.98M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $61.24M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.83B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.77B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.26B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $4.34B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 19.99M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $153K |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $3.76M |
| Capex | Q1 2025 · Mar 31, 2024 | $881K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $11.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $371.64M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $369.13M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.32 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.32 |
| Net Income | Q1 2025 · Mar 31, 2024 | $6.43M |